These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 35285924)

  • 81. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Adapting the Canadian CT head rule age criteria for mild traumatic brain injury.
    Fournier N; Gariepy C; Prévost JF; Belhumeur V; Fortier É; Carmichael PH; Gariepy JL; Le Sage N; Émond M
    Emerg Med J; 2019 Oct; 36(10):617-619. PubMed ID: 31326953
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Serum biomarkers identify critically ill traumatic brain injury patients for MRI.
    Richter S; Winzeck S; Czeiter E; Amrein K; Kornaropoulos EN; Verheyden J; Sugar G; Yang Z; Wang K; Maas AIR; Steyerberg E; Büki A; Newcombe VFJ; Menon DK;
    Crit Care; 2022 Nov; 26(1):369. PubMed ID: 36447266
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Isolated Traumatic Subarachnoid Hemorrhage on Head Computed Tomography Scan May Not Be Isolated: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (TRACK-TBI) Study.
    Yue JK; Yuh EL; Elguindy MM; Sun X; van Essen TA; Deng H; Belton PJ; Satris GG; Wong JC; Valadka AB; Korley FK; Robertson CS; McCrea MA; Stein MB; Diaz-Arrastia R; Wang KKW; Temkin NR; DiGiorgio AM; Tarapore PE; Huang MC; Markowitz AJ; Puccio AM; Mukherjee P; Okonkwo DO; Jain S; Manley GT
    J Neurotrauma; 2024 Jun; 41(11-12):1310-1322. PubMed ID: 38450561
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Rodríguez-Rodríguez A; El Rahal A; Quintana-Diaz M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Montaner J; Sanchez JC
    PLoS One; 2018; 13(7):e0200394. PubMed ID: 29985933
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Integrated Assessment of GFAP and UCH-L1 for their utility in severity assessment and outcome prediction in Traumatic Brain Injury.
    Mathew D; Purohit P; Gadwal A; Anil A; Sharma RK; Meshram VP; Setia P
    Int J Legal Med; 2024 Jul; ():. PubMed ID: 38977505
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of the Canadian CT head rule and the new orleans criteria in patients with minor head injury.
    Kavalci C; Aksel G; Salt O; Yilmaz MS; Demir A; Kavalci G; Akbuga Ozel B; Altinbilek E; Durdu T; Yel C; Durukan P; Isik B
    World J Emerg Surg; 2014; 9():31. PubMed ID: 24742359
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Canadian CT head rule and New Orleans Criteria in mild traumatic brain injury: comparison at a tertiary referral hospital in Japan.
    Mata-Mbemba D; Mugikura S; Nakagawa A; Murata T; Kato Y; Tatewaki Y; Takase K; Kushimoto S; Tominaga T; Takahashi S
    Springerplus; 2016; 5():176. PubMed ID: 27026873
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury.
    Anderson TN; Hwang J; Munar M; Papa L; Hinson HE; Vaughan A; Rowell SE
    J Trauma Acute Care Surg; 2020 Jul; 89(1):80-86. PubMed ID: 32251265
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury.
    Kobeissy F; Arja RD; Munoz JC; Shear DA; Gilsdorf J; Zhu J; Yadikar H; Haskins W; Tyndall JA; Wang KK
    Expert Rev Mol Diagn; 2024; 24(1-2):67-77. PubMed ID: 38275158
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.
    McMahon PJ; Panczykowski DM; Yue JK; Puccio AM; Inoue T; Sorani MD; Lingsma HF; Maas AI; Valadka AB; Yuh EL; Mukherjee P; Manley GT; Okonkwo DO;
    J Neurotrauma; 2015 Apr; 32(8):527-33. PubMed ID: 25264814
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Accuracy of Canadian CT head rule in predicting positive findings on CT of the head of patients after mild head injury in a large trauma centre in Saudi Arabia.
    Arab AF; Ahmed ME; Ahmed AE; Hussein MA; Khankan AA; Alokaili RN
    Neuroradiol J; 2015 Dec; 28(6):591-7. PubMed ID: 26471399
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
    Luger S; Jæger HS; Dixon J; Bohmann FO; Schaefer J; Richieri SP; Larsen K; Hov MR; Bache KG; Foerch C;
    Neurocrit Care; 2020 Aug; 33(1):39-48. PubMed ID: 32096121
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy].
    Jiang SH; Wang JX; Zhang YM; Jiang HF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1193-6. PubMed ID: 25523563
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Head Injury Evaluation and Ambulance Diagnosis (HOME) Study protocol: a feasibility study assessing the implementation of the Canadian CT Head Rule in the prehospital setting.
    Alqurashi N; Bell S; Carley SD; Lecky F; Body R
    BMJ Open; 2024 Jun; 14(6):e077191. PubMed ID: 38862222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.